231 related articles for article (PubMed ID: 17323836)
1. Current trends in multiple sclerosis research: an update on pathogenic concepts.
Vanderlocht J; Hellings N; Hendriks JJ; Stinissen P
Acta Neurol Belg; 2006 Dec; 106(4):180-90. PubMed ID: 17323836
[TBL] [Abstract][Full Text] [Related]
2. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
Zozulya AL; Wiendl H
Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
[TBL] [Abstract][Full Text] [Related]
3. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
Ji Q; Goverman J
Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
[TBL] [Abstract][Full Text] [Related]
4. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
Johnson AJ; Suidan GL; McDole J; Pirko I
Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
Taoufik E; Tseveleki V; Euagelidou M; Emmanouil M; Voulgari-Kokota A; Haralambous S; Probert L
Neurodegener Dis; 2008; 5(1):32-7. PubMed ID: 18075273
[TBL] [Abstract][Full Text] [Related]
6. The pathology of MS: new insights and potential clinical applications.
Pittock SJ; Lucchinetti CF
Neurologist; 2007 Mar; 13(2):45-56. PubMed ID: 17351524
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenesis and immunotherapy of multiple sclerosis.
Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
[TBL] [Abstract][Full Text] [Related]
8. The immunopathogenesis of multiple sclerosis.
Giovannoni G
Baillieres Clin Neurol; 1997 Oct; 6(3):387-407. PubMed ID: 10101580
[TBL] [Abstract][Full Text] [Related]
9. Immunologic aspects of multiple sclerosis.
Boppana S; Huang H; Ito K; Dhib-Jalbut S
Mt Sinai J Med; 2011; 78(2):207-20. PubMed ID: 21425265
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific blockade of lethal CD8 T-cell mediated autoimmunity in a mouse model of multiple sclerosis.
Na SY; Eujen H; Göbel K; Meuth SG; Martens K; Wiendl H; Hünig T
J Immunol; 2009 May; 182(10):6569-75. PubMed ID: 19414812
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cells in inflammatory demyelinating disease.
Weiss HA; Millward JM; Owens T
J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
[TBL] [Abstract][Full Text] [Related]
12. Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
Waxman SG
Nat Rev Neurosci; 2006 Dec; 7(12):932-41. PubMed ID: 17115075
[TBL] [Abstract][Full Text] [Related]
13. Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies.
Kieseier BC; Hartung HP
Exp Neurol; 2007 Jan; 203(1):1-4. PubMed ID: 17069803
[No Abstract] [Full Text] [Related]
14. Multiple sclerosis.
Hafler DA; Slavik JM; Anderson DE; O'Connor KC; De Jager P; Baecher-Allan C
Immunol Rev; 2005 Apr; 204():208-31. PubMed ID: 15790361
[TBL] [Abstract][Full Text] [Related]
15. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy.
Kieseier BC; Archelos JJ; Storch M; Gold R; Hartung HP
Wien Klin Wochenschr; 1999 Sep; 111(17):728-37. PubMed ID: 10526397
[TBL] [Abstract][Full Text] [Related]
16. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
Cassan C; Liblau RS
J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: an immune or neurodegenerative disorder?
Trapp BD; Nave KA
Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855
[TBL] [Abstract][Full Text] [Related]
18. Future immunotherapies in multiple sclerosis.
Blevins G; Martin R
Semin Neurol; 2003 Jun; 23(2):147-58. PubMed ID: 12894380
[TBL] [Abstract][Full Text] [Related]
19. The future of multiple sclerosis treatment.
Cohen JA
J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
Stojkov D; Lavrnja I; Pekovic S; Dacic S; Bjelobaba I; Mostarica-Stojkovic M; Stosic-Grujicic S; Jovanovic S; Nedeljkovic N; Rakic L; Stojiljkovic M
J Neurol Sci; 2008 Apr; 267(1-2):76-85. PubMed ID: 17996253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
